On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...